Kimia Biosciences Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 263659, "name": "Kimia Bioscien.", "stock_name": "Kimia Bioscien.", "full_name": "Kimia Biosciences Ltd", "name_url": "stocks-analysis/kimia-bioscien", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "37.50", "chg": 1.01, "chgp": "2.77%", "dir": 1, "prev_price": "36.49", "mcapval": "177.42 Cr", "mcap": "Micro Cap", "scripcode": 530313, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE285U01025", "curr_date": "Apr 21", "curr_time": "", "bse_nse_vol": "3.27 k", "exc_status": "Active", "traded_date": "Apr 21, 2026", "traded_date_str": "2026 04 21", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kimia-bioscien-263659-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Kimia Biosciences Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-sell-3955708", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KimiaBioscience_mojoScore_3955708.png", "date": "2026-04-21 10:10:52", "description": "Kimia Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Kimia Biosciences Ltd Upgraded to Sell on Technical Improvement Despite Lingering Fundamental Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-upgraded-to-sell-on-technical-improvement-despite-lingering-fundamental-concerns-3940986", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KimiaBioscience_mojoScore_3940986.png", "date": "2026-04-10 08:03:46", "description": "Kimia Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 9 April 2026, driven primarily by improvements in its technical outlook despite ongoing fundamental challenges. This shift reflects a nuanced reassessment across quality, valuation, financial trends, and technical indicators, signalling a cautious but more optimistic stance on the micro-cap pharmaceutical company." }, { "title": "Kimia Biosciences Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-3934084", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KimiaBioscience_mojoScore_3934084.png", "date": "2026-04-06 10:10:39", "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Kimia Biosciences Ltd Falls to 52-Week Low of Rs 23.2 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-ltd-falls-to-52-week-low-amidst-continued-downtrend-3924271", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KimiaBioscience_priceRelatedfactors_3924271.png", "date": "2026-03-30 10:31:40", "description": "A sharp decline over the past three sessions has dragged Kimia Biosciences Ltd to a fresh 52-week low of Rs 23.2 on 30 Mar 2026, marking a 12.77% loss in that period and extending its underperformance well beyond the broader market's modest retreat." }, { "title": "Kimia Biosciences Falls 13.45%: Downgrade and 52-Week Low Mark a Challenging Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-falls-1345-downgrade-and-52-week-low-mark-a-challenging-week-3922233", "imagepath": "", "date": "2026-03-28 16:11:31", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 23:</strong> Downgrade to Strong Sell announced; stock closes at Rs.28.00 (-4.44%)</p>\n <p><strong>Mar 24:</strong> Stock rebounds modestly to Rs.28.67 (+2.39%) amid broader market gains</p>\n <p><strong>Mar 25:</strong> Slight decline to Rs.28.46 (-0.73%) despite Sensex rally</p>\n <p><strong>Mar 27:</strong> Stock plunges to 52-week low of Rs.24, closing at Rs.25.36 (-10.89%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.29.30</div></div>\n <div class=\"stat-item\"><div class=..." }, { "title": "Kimia Biosciences Ltd Falls to 52-Week Low of Rs 24 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-ltd-stock-falls-to-52-week-low-of-rs24-3920321", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KimiaBioscience_priceRelatedfactors_3920321.png", "date": "2026-03-27 15:46:08", "description": "A sharp decline in Kimia Biosciences Ltd has pushed the stock to a fresh 52-week low of Rs 24 on 27 Mar 2026, marking a significant 44.19% drop over the past year and a 16.29% fall in just the last two sessions. This downturn comes amid a broader market sell-off, but the stock’s underperformance far exceeds sector and benchmark indices, raising questions about the underlying factors driving this weakness." }, { "title": "Kimia Biosciences Downgraded to Strong Sell Amid Deteriorating Technicals and Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-downgraded-to-strong-sell-amid-deteriorating-technicals-and-weak-fundamentals-3909316", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KimiaBioscience_mojoScore_3909316.png", "date": "2026-03-24 08:07:50", "description": "Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 23 March 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s overall outlook remains bleak due to high debt levels, poor long-term growth, and underperformance relative to the broader market." }, { "title": "Kimia Biosciences Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3884493", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KimiaBioscience_mojoScore_3884493.png", "date": "2026-03-11 08:05:17", "description": "Kimia Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 10 March 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The company’s Mojo Score improved to 34.0, reflecting a modestly less negative outlook, while the Mojo Grade moved from Strong Sell to Sell. This article analyses the four key parameters influencing this rating change: Quality, Valuation, Financial Trend, and Technicals." }, { "title": "Kimia Biosciences Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-3865871", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KimiaBioscience_mojoScore_3865871.png", "date": "2026-03-03 08:10:56", "description": "Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 2 March 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s long-term growth prospects remain subdued, compounded by high leverage and underperformance relative to the broader market." } ], "total": 188, "sid": "263659", "stock_news_url": "https://www.marketsmojo.com/news/kimia-biosciences-263659" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "18-Apr-2026", "details": "Outcome of Board Meeting held on 18 April 2026 under regulation 30 of Sebi(Lodr) Regulations 2015 - Change in Management", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "15-Apr-2026", "details": "Compliance certificate under Reg. 74(5) of SEBI (DP)Regulations 2018 for quarter ending March 31 2026.", "source": "BSE" }, { "caption": "Clarification On Price Movement In The Scrip Of The Company - BSE Email Dated April 13 2026 Bearing Reference No. L/SURV/ONL/PV/APJ/2026-2027/3695- Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "14-Apr-2026", "details": "We would like to inform you that company is in compliance with provision of Reg 30 of SEBI(LODR) Regulations 2015 and has been promptly intimating to exchange all events information and announcement that may have bearing on operation and performance of the company. There is no undisclosed price sensitive information or any pending announcement/corporate action which in our opinion may have a bearing on price movement in the scrip of the company. The movement in share price is purely market driven and company has no control over the same.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 23: Downgrade to Strong Sell announced; stock closes at Rs.28.00 (-4.44%)

Mar 24: Stock rebounds modestly to Rs.28.67 (+2.39%) amid broader market gains

Mar 25: Slight decline to Rs.28.46 (-0.73%) despite Sensex rally

Mar 27: Stock plunges to 52-week low of Rs.24, closing at Rs.25.36 (-10.89%)

Week Open

Rs.29.30

Read full news article

Kimia Biosciences Ltd Falls to 52-Week Low of Rs 24 as Sell-Off Deepens

2026-03-27 15:46:08

A sharp decline in Kimia Biosciences Ltd has pushed the stock to a fresh 52-week low of Rs 24 on 27 Mar 2026, marking a significant 44.19% drop over the past year and a 16.29% fall in just the last two sessions. This downturn comes amid a broader market sell-off, but the stock’s underperformance far exceeds sector and benchmark indices, raising questions about the underlying factors driving this weakness.

Read full news article

Kimia Biosciences Downgraded to Strong Sell Amid Deteriorating Technicals and Weak Fundamentals

2026-03-24 08:07:50

Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 23 March 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s overall outlook remains bleak due to high debt levels, poor long-term growth, and underperformance relative to the broader market.

Read full news article

Kimia Biosciences Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-03-11 08:05:17

Kimia Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 10 March 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The company’s Mojo Score improved to 34.0, reflecting a modestly less negative outlook, while the Mojo Grade moved from Strong Sell to Sell. This article analyses the four key parameters influencing this rating change: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

Kimia Biosciences Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns

2026-03-03 08:10:56

Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 2 March 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s long-term growth prospects remain subdued, compounded by high leverage and underperformance relative to the broader market.

Read full news article